Legal & Medical Disclaimer
This content is for informational purposes only and does not constitute legal, medical, or professional advice.
Regulations vary by state and change frequently. The information provided may become outdated. Always verify current regulations with your state board of pharmacy, legal counsel, or regulatory authority before making operational decisions.
RX Agent and its contributors assume no liability for actions taken based on this information. Consult qualified legal and medical professionals for guidance specific to your situation.
Effective As Of: December 2025
Zade Shammout, PharmD
Pharmacy Compliance Specialists
Our team of licensed pharmacists and regulatory experts continuously monitor federal and state pharmacy laws to ensure accuracy and compliance.
Last reviewed: December 2025
Why State-Specific Compliance Matters
Prescription medication laws vary dramatically across the United States, and non-compliance can result in license suspension, fines, or criminal charges.
While federal agencies (DEA and FDA) set baseline requirements, each state maintains its own Board of Pharmacy with unique regulations governing prescribing authority, dispensing requirements, record-keeping, and controlled substance monitoring programs (PDMPs).
This hub page covers federal law and links to detailed state-specific guides. Click your state on the interactive map below or select from the list.
Select Your State for Specific Requirements
Federal Law: DEA & FDA Requirements
DEA (Drug Enforcement Administration)
The DEA regulates controlled substances under the Controlled Substances Act (CSA), classifying drugs into Schedules I-V based on abuse potential and medical use.
- Schedule II: Highest potential for abuse with accepted medical use (opioids, stimulants). No refills allowed.
- Schedule III-V: Lower abuse potential. Limited refills (III-IV: up to 5 refills within 6 months).
- DEA Registration: Required for all prescribers and dispensers handling controlled substances.
- Record-Keeping: Prescribers must maintain records for 2 years; pharmacies for 2-3 years depending on state.
- Electronic Prescriptions (EPCS): Required in many states for Schedule II-V controlled substances.
FDA (Food and Drug Administration)
The FDA oversees drug approval, labeling, safety monitoring (MedWatch), and REMS (Risk Evaluation and Mitigation Strategies) programs.
- Drug Approval: All prescription medications must be FDA-approved before marketing.
- REMS Programs: Required for high-risk medications (e.g., isotretinoin, clozapine). Prescribers must register and complete training.
- Adverse Event Reporting: Healthcare providers should report serious adverse events via MedWatch.
- Off-Label Use: Legal but requires informed consent and documentation.
Browse by State (A-Z)
Key Compliance Topics Across All States
Prescription Drug Monitoring Programs (PDMPs)
Nearly all states require prescribers to check PDMPs before prescribing controlled substances. Check your state for specific query timeframes and exemptions.
Telemedicine Prescribing
State requirements vary for establishing patient relationships, prescribing controlled substances, and out-of-state licensure. Ryan Haight Act restricts Schedule II-V telemedicine prescribing without in-person exam (federal).
Collaborative Practice Agreements
Many states allow pharmacists to prescribe under collaborative practice agreements (CPAs) with physicians. Scope varies by state.
Opioid Prescribing Limits
Many states impose day-supply limits for initial opioid prescriptions (typically 3-7 days). Check your state for specifics.
Naloxone Co-Prescribing Requirements
Some states require or recommend prescribing naloxone alongside opioids for high-risk patients.
Need Real-Time Compliance Guidance?
RX Agent provides AI-powered answers to your prescribing and dispensing questions with state-specific citations and up-to-date regulatory guidance.
Try RX Agent Free